London, 27 April 2022; Consilium Strategic Communications, a global leader in strategic healthcare communications and investor relations, is proud to have supported Cambridge Innovation Capital on the closing of its oversubscribed second fund at £225million ($300 million).
Cambridge Innovation Capital is the venture capital investor focused on building world-leading deeptech and life sciences businesses connected with the Cambridge ecosystem. With Fund II, CIC now manages in excess of £500 million, giving it the scale to support its portfolio companies throughout their life cycle, providing investment capital as well as strategic and operational support.
“This fund close is a testament to CIC’s unique investment model, and the talented team at CIC. We would like to congratulate Andrew and the team on this successful fundraise and we are proud to have supported CIC to communicate its news globally,” said Mary-Jane Elliott, Founder and Managing Partner of Consilium Strategic Communications.
“The closing of Fund II is an important milestone for Cambridge Innovation Capital. The Cambridge ecosystem is reaching a concentration of research and innovation that I have only previously seen when working in Silicon Valley. We worked with Consilium on this key piece of news due to their experience and ability to dedicate time and resource to delivering a bespoke project. Hats off to them – they did a great job and are a pleasure to work with,” said Andrew Williamson, Managing Partner of CIC.
The Consilium team representing Cambridge Innovation Capital on the fund closing was Mary-Jane Elliott, Sukaina Virji, Andrew Stern and Jessica Pilling.
To view Cambridge Innovation Capital’s announcement, please visit www.cic.vc.
